{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:57:36Z","timestamp":1793451456752,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"publisher","award":["EX-60%"],"award-info":[{"award-number":["EX-60%"]}],"id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","award":["2020.1694"],"award-info":[{"award-number":["2020.1694"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41417-024-00783-7","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:02:25Z","timestamp":1715594545000},"page":"1266-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer"],"prefix":"10.1038","volume":"31","author":[{"given":"Letizia","family":"Rinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Compagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cedrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vissio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Delsedime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bussolati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Arvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-8245","authenticated-orcid":false,"given":"Maria Graziella","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1200\/JCO.18.00606","volume":"36","author":"JE Bekelman","year":"2018","unstructured":"Bekelman JE, Rumble RB, Chen RC, Pisansky TM, Finelli A, Feifer A, et al. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association\/American Society for Radiation Oncology\/Society of Urologic Oncology Guideline. J Clin Oncol. 2018;36:3251\u20138.","journal-title":"J Clin Oncol"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa1503747","volume":"373","author":"CJ Sweeney","year":"2015","unstructured":"Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015;373:737\u201346.","journal-title":"N Engl J Med"},{"key":"783_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad078","volume":"164","author":"AW Hahn","year":"2023","unstructured":"Hahn AW, Siddiqui BA, Leo J, Dondossola E, Basham KJ, Miranti CK, et al. Cancer cell-extrinsic roles for the androgen receptor in prostate cancer. Endocrinology. 2023;164:bqad078.","journal-title":"Endocrinology"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.3390\/cancers15092552","volume":"15","author":"CM Gillette","year":"2023","unstructured":"Gillette CM, Yette GA, Cramer SD, Graham LS. Management of advanced prostate cancer in the precision oncology era. Cancers (Basel). 2023;15:2552.","journal-title":"Cancers (Basel)"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701\u201311.","journal-title":"Nat Rev Cancer"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/onc.2013.206","volume":"32","author":"T Karantanos","year":"2013","unstructured":"Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene. 2013;32:5501\u201311.","journal-title":"Oncogene"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461\u201373.","journal-title":"Oncogene"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/annonc\/mdx689","volume":"29","author":"L Wang","year":"2018","unstructured":"Wang L, Dehm SM, Hillman DW, Sicotte H, Tan W, Gormley M, et al. A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone. Ann Oncol. 2018;29:352\u201360.","journal-title":"Ann Oncol"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eururo.2019.05.032","volume":"77","author":"P Isaacsson Velho","year":"2020","unstructured":"Isaacsson Velho P, Fu W, Wang H, Mirkheshti N, Qazi F, Lima FAS, et al. Wnt-pathway activating mutations are associated with resistance to first-line abiraterone and enzalutamide in castration-resistant prostate cancer. European Urology. 2020;77:14\u201321.","journal-title":"European Urology"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/0008-5472.CAN-19-1684","volume":"80","author":"R Patel","year":"2020","unstructured":"Patel R, Brzezinska EA, Repiscak P, Ahmad I, Mui E, Gao M, et al. Activation of \u03b2-catenin cooperates with loss of pten to drive AR-independent castration-resistant prostate cancer. Cancer Res. 2020;80:576\u201390.","journal-title":"Cancer Res"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: a comprehensive review. Cell Biol Int. 2022;46:863\u201377.","journal-title":"Cell Biol Int"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1111\/bph.13894","volume":"174","author":"MH Kagey","year":"2017","unstructured":"Kagey MH, He X. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. Br J Pharmacol. 2017;174:4637\u201350.","journal-title":"Br J Pharmacol"},{"key":"783_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.847387","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H, Zhang Z, Yu Y, Chu HY, Yu S, Yao S, et al. Drug discovery of DKK1 inhibitors. Front Pharmacol. 2022;13:847387.","journal-title":"Front Pharmacol"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med. 2003;349:2483\u201394.","journal-title":"N Engl J Med"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s13277-013-1411-x","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Tang W, Xie L, Wang J, Deng Y, Peng Q, et al. Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis. Tumour Biol. 2014;35:3145\u201354.","journal-title":"Tumour Biol"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1373\/clinchem.2009.125641","volume":"55","author":"SL Sheng","year":"2009","unstructured":"Sheng SL, Huang G, Yu B, Qin WX. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem. 2009;55:1656\u201364.","journal-title":"Clin Chem"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3349\/ymj.2015.56.5.1296","volume":"56","author":"SU Kim","year":"2015","unstructured":"Kim SU, Park JH, Kim HS, Lee JM, Lee HG, Kim H, et al. Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma. Yonsei Med J. 2015;56:1296\u2013306.","journal-title":"Yonsei Med J"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5301\/jbm.5000005","volume":"28","author":"T Jiang","year":"2013","unstructured":"Jiang T, Huang L, Zhang S. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer. Int J Biol Markers. 2013;28:221\u20135.","journal-title":"Int J Biol Markers"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/sj.onc.1209439","volume":"25","author":"O Aguilera","year":"2006","unstructured":"Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25:4116\u201321.","journal-title":"Oncogene"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-007-9867-2","volume":"112","author":"AM Mikheev","year":"2008","unstructured":"Mikheev AM, Mikheeva SA, Maxwell JP, Rivo JV, Rostomily R, Swisshelm K, et al. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells. Breast Cancer Res Treat. 2008;112:263\u201373.","journal-title":"Breast Cancer Res Treat"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mce.2012.12.007","volume":"366","author":"SW Cho","year":"2013","unstructured":"Cho SW, Lee EJ, Kim H, Kim SH, Ahn HY, Kim YA, et al. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of \u03b2-catenin\/E-cadherin signaling. Mol Cell Endocrinol. 2013;366:90\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/pros.21277","volume":"71","author":"NK Thudi","year":"2011","unstructured":"Thudi NK, Martin CK, Murahari S, Shu ST, Lanigan LG, Werbeck JL, et al. Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate. 2011;71:615\u201325.","journal-title":"Prostate"},{"key":"783_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-649","volume":"14","author":"TD Rachner","year":"2014","unstructured":"Rachner TD, Thiele S, G\u00f6bel A, Browne A, Fuessel S, Erdmann K, et al. High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer. 2014;14:649.","journal-title":"BMC Cancer"},{"key":"783_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-14-11","volume":"14","author":"P D\u2019Amelio","year":"2014","unstructured":"D\u2019Amelio P, Roato I, Oderda M, Soria F, Zitella A, Ferracini R, et al. DKK-1 in prostate cancer diagnosis and follow up. BMC Clin Pathol. 2014;14:11.","journal-title":"BMC Clin Pathol"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/pros.20805","volume":"68","author":"CL Hall","year":"2008","unstructured":"Hall CL, Daignault SD, Shah RB, Pienta KJ, Keller ET. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate. 2008;68:1396\u2013404.","journal-title":"Prostate"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/03008207.2018.1424147","volume":"59","author":"L Rinella","year":"2018","unstructured":"Rinella L, Marano F, Paletto L, Fraccalvieri M, Annaratone L, Castellano I, et al. Extracorporeal shock waves trigger tenogenic differentiation of human adipose-derived stem cells. Connect Tissue Res. 2018;59:561\u201373.","journal-title":"Connect Tissue Res"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"e3627","DOI":"10.1371\/journal.pone.0003627","volume":"3","author":"I Roato","year":"2008","unstructured":"Roato I, D\u2019Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, et al. Osteoclasts are active in bone forming metastases of prostate cancer patients. PLoS ONE. 2008;3:e3627.","journal-title":"PLoS ONE"},{"key":"783_CR29","doi-asserted-by":"publisher","first-page":"12921","DOI":"10.3390\/ijms222312921","volume":"22","author":"I Giralt","year":"2021","unstructured":"Giralt I, Gallo-Oller G, Navarro N, Zarzosa P, Pons G, Magdaleno A, et al. Dickkopf-1 inhibition reactivates Wnt\/\u03b2-catenin signaling in rhabdomyosarcoma, induces myogenic markers in vitro and impairs tumor cell survival in vivo. IJMS. 2021;22:12921.","journal-title":"IJMS"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1158\/0008-5472.CAN-10-0440","volume":"70","author":"CL Hall","year":"2010","unstructured":"Hall CL, Zhang H, Baile S, Ljungman M, Kuhstoss S, Keller ET. p21CIP-1\/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1. Cancer Res. 2010;70:9916\u201326.","journal-title":"Cancer Res"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1139\/bcb-2017-0015","volume":"96","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wang J, Chen Z, Wang K, Shi L. MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1. Biochem Cell Biol. 2018;96:355\u201364.","journal-title":"Biochem Cell Biol"},{"key":"783_CR32","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/ijc.24865","volume":"126","author":"N Takahashi","year":"2010","unstructured":"Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer. 2010;126:1611\u201320.","journal-title":"Int J Cancer"},{"key":"783_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1349-7006.2012.02222.x","volume":"103","author":"L Qi","year":"2012","unstructured":"Qi L, Sun B, Liu Z, Li H, Gao J, Leng X. Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci. 2012;103:828\u201335.","journal-title":"Cancer Sci"},{"key":"783_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12:385\u201392.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"783_CR35","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2008.47","volume":"15","author":"H Vakifahmetoglu","year":"2008","unstructured":"Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 2008;15:1153\u201362.","journal-title":"Cell Death Differ"},{"key":"783_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4143\/crt.2016.168","volume":"49","author":"S Kim","year":"2017","unstructured":"Kim S, Min A, Lee KH, Yang Y, Kim TY, Lim JM, et al. Antitumor effect of KX-01 through inhibiting Src family kinases and mitosis. Cancer Res Treat. 2017;49:643\u201355.","journal-title":"Cancer Res Treat"},{"key":"783_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","volume":"121","author":"SHM Wong","year":"2018","unstructured":"Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC. E-cadherin: Its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol. 2018;121:11\u201322.","journal-title":"Crit Rev Oncol Hematol"},{"key":"783_CR38","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8:1118.","journal-title":"Cells"},{"key":"783_CR39","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/jcmm.12862","volume":"20","author":"L Yao","year":"2016","unstructured":"Yao L, Zhang D, Zhao X, Sun B, Liu Y, Gu Q, et al. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. J Cell Mol Med. 2016;20:1673\u201385.","journal-title":"J Cell Mol Med"},{"key":"783_CR40","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.7150\/thno.27667","volume":"8","author":"P Zhang","year":"2018","unstructured":"Zhang P, Li S, Lv C, Si J, Xiong Y, Ding L, et al. BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1. Theranostics. 2018;8:5890\u2013902.","journal-title":"Theranostics"},{"key":"783_CR41","first-page":"6739","volume":"15","author":"H Pang","year":"2018","unstructured":"Pang H, Ma N, Shen W, Zhao Q, Wang J, Duan L, et al. Effects of DKK1 overexpression on bone metastasis of SBC-3 cells. Oncol Lett. 2018;15:6739\u201344.","journal-title":"Oncol Lett"},{"key":"783_CR42","doi-asserted-by":"publisher","first-page":"20481","DOI":"10.18632\/aging.203430","volume":"13","author":"Q Song","year":"2021","unstructured":"Song Q, Liu H, Li C, Liang H. miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt\/\u03b2-catenin pathway. Aging (Albany NY). 2021;13:20481\u201394.","journal-title":"Aging (Albany NY)"},{"key":"783_CR43","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1158\/0008-5472.CAN-09-3016","volume":"70","author":"CF Huang","year":"2010","unstructured":"Huang CF, Lira C, Chu K, Bilen MA, Lee YC, Ye X, et al. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010;70:4580\u20139.","journal-title":"Cancer Res"},{"key":"783_CR44","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1158\/1541-7786.MCR-08-0077","volume":"6","author":"K Chu","year":"2008","unstructured":"Chu K, Cheng CJ, Ye X, Lee YC, Zurita AJ, Chen DT, et al. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008;6:1259\u201367.","journal-title":"Mol Cancer Res"},{"key":"783_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/path.2687","volume":"221","author":"YC Lee","year":"2010","unstructured":"Lee YC, Cheng CJ, Huang M, Bilen MA, Ye X, Navone NM, et al. Androgen depletion up-regulates cadherin-11 expression in prostate cancer. J Pathol. 2010;221:68\u201376.","journal-title":"J Pathol"},{"key":"783_CR46","first-page":"4788","volume":"11","author":"SH Seo","year":"2021","unstructured":"Seo SH, Cho KJ, Park HJ, Kim H, Lee HW, Kim BK, et al. Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR\/p70S6K signaling in hepatocellular carcinoma. Am J Cancer Res. 2021;11:4788\u2013806.","journal-title":"Am J Cancer Res"},{"key":"783_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115378","volume":"208","author":"RH Yang","year":"2023","unstructured":"Yang RH, Qin J, Cao JL, Zhang MZ, Li YY, Wang MQ, et al. Dickkopf-1 drives tumor immune evasion by inducing PD-L1 expression in hepatocellular carcinoma. Biochem Pharmacol. 2023;208:115378.","journal-title":"Biochem Pharmacol"},{"key":"783_CR48","doi-asserted-by":"publisher","first-page":"e75092","DOI":"10.1371\/journal.pone.0075092","volume":"8","author":"A Fradet","year":"2013","unstructured":"Fradet A, Sorel H, Depalle B, Serre CM, Farlay D, Turtoi A, et al. A new murine model of osteoblastic\/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE. 2013;8:e75092.","journal-title":"PLoS ONE"},{"key":"783_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"783_CR50","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.3390\/ijms22094358","volume":"22","author":"N Mahmood","year":"2021","unstructured":"Mahmood N, Rabbani SA. Fibrinolytic system and cancer: diagnostic and therapeutic applications. Int J Mol Sci. 2021;22:4358.","journal-title":"Int J Mol Sci"},{"key":"783_CR51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00633.2023","author":"JH Longstreth","year":"2024","unstructured":"Longstreth JH, Wang K. The role of fibronectin in mediating cell migration. Am J Physiol Cell Physiol. 2024. https:\/\/doi.org\/10.1152\/ajpcell.00633.2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"783_CR52","first-page":"2365","volume":"61","author":"Y Jiang","year":"2001","unstructured":"Jiang Y, Wang M, Celiker MY, Liu YE, Sang QX, Goldberg ID, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Cancer Res. 2001;61:2365\u201370.","journal-title":"Cancer Res"},{"key":"783_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02477-1","volume":"21","author":"J Han","year":"2021","unstructured":"Han J, Jing Y, Han F, Sun P. Comprehensive analysis of expression, prognosis and immune infiltration for TIMPs in glioblastoma. BMC Neurol. 2021;21:447.","journal-title":"BMC Neurol"},{"key":"783_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/apm.12638","volume":"125","author":"M Janiak","year":"2017","unstructured":"Janiak M, Paskal W, Rak B, Garbicz F, Jarema R, Sikora K, et al. TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells. APMIS. 2017;125:101\u20135.","journal-title":"APMIS"},{"key":"783_CR55","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/modpathol.2010.136","volume":"23","author":"S Rorive","year":"2010","unstructured":"Rorive S, Lopez XM, Maris C, Trepant AL, Sauvage S, Sadeghi N, et al. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Mod Pathol. 2010;23:1418\u201328.","journal-title":"Mod Pathol"},{"key":"783_CR56","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bbrc.2013.12.076","volume":"443","author":"T Chu","year":"2014","unstructured":"Chu T, Teng J, Jiang L, Zhong H, Han B. Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation. Biochem Biophys Res Commun. 2014;443:962\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"783_CR57","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ncb3613","volume":"19","author":"X Zhuang","year":"2017","unstructured":"Zhuang X, Zhang H, Li X, Li X, Cong M, Peng F, et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1. Nat Cell Biol. 2017;19:1274\u201385.","journal-title":"Nat Cell Biol"},{"key":"783_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1114822","volume":"13","author":"D Doucet","year":"2023","unstructured":"Doucet D, Brubaker C, Turner D, Gregory CA. Factors affecting the role of canonical Wnt inhibitor Dickkopf-1 in cancer progression. Front Oncol. 2023;13:1114822.","journal-title":"Front Oncol"},{"key":"783_CR59","doi-asserted-by":"publisher","first-page":"21114","DOI":"10.18632\/oncotarget.8522","volume":"7","author":"SD Goldstein","year":"2016","unstructured":"Goldstein SD, Trucco M, Guzman WB, Hayashi M, Loeb DM. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. Oncotarget. 2016;7:21114\u201323.","journal-title":"Oncotarget"},{"key":"783_CR60","first-page":"55","volume":"154","author":"I Betella","year":"2019","unstructured":"Betella I, Turbitt WJ, Szul T, Wu B, Martinez AA, Arend RC, et al. Dkn-01: a promising strategy for targeting the Wnt pathway in ovarian cancer. Gynecol Oncol. 2019;154:55.","journal-title":"Gynecol Oncol"},{"key":"783_CR61","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ygyno.2020.03.010","volume":"157","author":"I Betella","year":"2020","unstructured":"Betella I, Turbitt WJ, Szul T, Wu B, Martinez A, Katre A, et al. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer. Gynecol Oncol. 2020;157:765\u201374.","journal-title":"Gynecol Oncol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00783-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T08:02:13Z","timestamp":1723708933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00783-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1038\/s41417-024-00783-7","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal studies were conducted in accordance with the Italian National Institute of Health Guide for the Care and Use of Laboratory Animals (authorization n\u00b0 521\/2021-PR, July 19, 2021). Mice were housed according to the guidelines of the Federation of European Laboratory Animal Science Association and the Ethical Committee of the University of Turin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}